Covered recipient · General Payments record
MERON TESHOME
Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology
General Payments · PY2018–2024
$5,378.04
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,051.82 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $411.43 | 4 |
| BOSTON SCIENTIFIC CORPORATION | $187.13 | 6 |
| Abbott Laboratories | $170.62 | 1 |
| Penumbra, Inc. | $137.88 | 1 |
| CVRx Inc. | $98.26 | 1 |
| Inari Medical, Inc. | $23.76 | 1 |
| PFIZER INC. | $16.25 | 1 |
| Aziyo Biologics, Inc. | $6.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $170.62 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125257524 | CMS |
| ABIOMED | $120.00 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142281231 | CMS |
| ABIOMED | $128.46 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142281343 | CMS |
| ABIOMED | $27.57 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142281355 | CMS |
| ABIOMED | $135.40 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142281357 | CMS |
| Boston Scientific Corporation | $18.35 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092474089 | CMS |
| Boston Scientific Corporation | $8.12 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092474085 | CMS |
| Boston Scientific Corporation | $146.12 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092474091 | CMS |
| Boston Scientific Corporation | $4.15 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092474083 | CMS |
| Boston Scientific Corporation | $2.17 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092474081 | CMS |
| Boston Scientific Corporation | $8.22 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092474087 | CMS |
| CVRx, Inc. | $98.26 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138736210 | CMS |
| Elutia, Inc. | $6.49 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130723881 | CMS |
| Inari Medical, Inc. | $23.76 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140169920 | CMS |
| Penumbra, Inc. | $137.88 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1076220676 | CMS |
| PFIZER INC. | $16.25 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131657759 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.